Fathom Therapeutics Scores $47 Million Series A

Fathom Therapeutics Scores $47 Million Series A

Summary

NEW YORK, NY, Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by predicting their behav...

Description

NEW YORK, NY, Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by predicting their behav...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage